Bruised Over Humira Patent Games, AbbVie Sees Smoother Road With Botox

 
• By Cathy Kelly

AbbVie’s proposed acquisition of Allergan unites two companies that have gained notoriety for their exhaustive and unconventional efforts, respectively, to extend the patents of key products.

car on a road in the countryside - Image
Biosimilar Competition For Botox Unlikely In Near Term, AbbVie Says • Source: Shutterstock

More from Drug Pricing

More from Scrip